(Q58811102)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776733%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

title

Hyperinsulinaemic androgen excess in adolescent girls (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776733%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776733%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

David B. Dunger

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776733%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

2

Ken K Ong

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776733%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

5

Francis de Zegher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776733%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

3

Abel López-Bermejo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776733%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

publication date

29 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776733%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Endocrinology

16 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776733%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776733%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776733%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

page(s)

499-508

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776733%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrendo.2014.58

16 March 2020

exact match

0 references

cites work

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Insulin resistance in nonobese patients with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Adipose tissue expandability and the early origins of PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Development of obesity and polycystic ovary syndrome in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Clinical review: Adolescent anovulation: maturational mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Prevalence of polycystic ovary syndrome in adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Prevalence of polycystic ovarian syndrome in Indian adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Type 2 diabetes, cardiovascular disease, and the evolutionary paradox of the polycystic ovary syndrome: a fertility first hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

The Polycystic Ovary Syndrome and recent human evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Physical Activity, Body Mass Index, and Ovulatory Disorder Infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Eating up the world's food web and the human trophic level

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Associations between red meat intake and biomarkers of inflammation and glucose metabolism in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Ethnic differences in the phenotypic expression of polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Ethnic variability in adiposity, thrifty phenotypes and cardiometabolic risk: addressing the full range of ethnicity, including those of mixed ethnicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Abundance of circulating preadipocyte factor 1 in early life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Effects of obesity on growth and puberty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Polycystic ovarian syndrome during puberty and adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Infancy weight gain predicts childhood body fat and age at menarche in girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Clinical review: Identifying children at risk for polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Low-birth weight children develop lower sex hormone binding globulin and higher dehydroepiandrosterone sulfate levels and aggravate their visceral adiposity and hypoadiponectinemia between six and eight years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Fetal programming: prenatal testosterone treatment causes intrauterine growth retardation, reduces ovarian reserve and increases ovarian follicular recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Developmental programming: excess weight gain amplifies the effects of prenatal testosterone excess on reproductive cyclicity--implication for polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Macrophages, fat, and the emergence of immunometabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

What we talk about when we talk about fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Influence of adiposity on insulin resistance and glycemia markers among U.K. Children of South Asian, black African-Caribbean, and white European origin: child heart and health study in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Polycystic ovary syndrome in adolescence: impaired glucose tolerance occurs across the spectrum of BMI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Reproductive tissues maintain insulin sensitivity in diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Maturation of luteinizing hormone (gonadotropin-releasing hormone) secretion across puberty: evidence for altered regulation in obese peripubertal girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Obesity and sex steroid changes across puberty: evidence for marked hyperandrogenemia in pre- and early pubertal obese girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Rescue of obesity-induced infertility in female mice due to a pituitary-specific knockout of the insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Obesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Glucose Intolerance, Insulin Resistance, and Hyperandrogenemia in First Degree Relatives of Women with Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Functional integrity of granulosa cells from polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Leptin substitution results in the induction of menstrual cycles in an adolescent with leptin deficiency and hypogonadotropic hypogonadism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Genetic Syndromes of Severe Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Androgen receptor gene CAG repeat polymorphism in the development of ovarian hyperandrogenism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Association of the CAG repeat polymorphisms in androgen receptor gene with polycystic ovary syndrome: a systemic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: phenotype and associated factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Menstruation in girls and adolescents: using the menstrual cycle as a vital sign

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Predictive value of menstrual cycle pattern, body mass index, hormone levels and polycystic ovaries at age 15 years for oligo-amenorrhoea at age 18 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Prevalence of hyperandrogenic states in late adolescent and young women: epidemiological survey on italian high-school students.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Clinical assessment of body hair growth in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Female adolescent hair disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Using the androgen excess-PCOS society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Clinical review: Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

The diagnosis of polycystic ovary syndrome in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Diagnosis and treatment of polycystic ovarian syndrome in adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Androgen profiling by liquid chromatography-tandem mass spectrometry (LC-MS/MS) in healthy normal-weight ovulatory and anovulatory late adolescent and young women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Serum anti-mullerian hormone concentrations are elevated in oligomenorrheic girls without evidence of hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Insulin resistance in children: consensus, perspective, and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Functional significance of polycystic-size ovaries in healthy adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Ultrasound assessment of the polycystic ovary: international consensus definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Polycystic ovaries in nonobese adolescents and young women with ovarian androgen excess: relation to prenatal growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Metformin Treatment to Prevent Early Puberty in Girls with Precocious Pubarche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Early metformin therapy to delay menarche and augment height in girls with precocious pubarche

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Hyperandrogenism in Adolescent Girls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Effect of lifestyle intervention on features of polycystic ovarian syndrome, metabolic syndrome, and intima-media thickness in obese adolescent girls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Effects of two forms of combined oral contraceptives on carbohydrate metabolism in adolescents with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Ethinyl estradiol-drospirenone vs ethinyl estradiol-drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Androgen and lipid profiles in adolescents with polycystic ovary syndrome who were treated with two forms of combined oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Oral contraception vs insulin sensitization for 18 months in nonobese adolescents with androgen excess: posttreatment differences in C-reactive protein, intima-media thickness, visceral adiposity, insulin sensitivity, and menstrual regularity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Treatment of androgen excess in adolescent girls: ethinylestradiol-cyproteroneacetate versus low-dose pioglitazone-flutamide-metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

A longitudinal comparison of body composition changes in adolescent girls receiving hormonal contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Hormonal contraception and thrombotic risk: a multidisciplinary approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Metformin for the treatment of the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Clinical review: Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Characteristics of interaction of the antiandrogen flutamide with the androgen receptor in various target tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Therapy: Low-dose flutamide for hirsutism: into the limelight, at last

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Regulation of LKB1 expression by sex hormones in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Impact of metformin monotherapy versus metformin with oestrogen-progesterone on lipids in adolescent girls with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Low-dose pioglitazone and low-dose flutamide added to metformin and oestro-progestagens for hyperinsulinaemic women with androgen excess: add-on benefits disclosed by a randomized double-placebo study over 24 months.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Pioglitazone prescription increases risk of bladder cancer in patients with type 2 diabetes: an updated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Effectiveness of Long-Acting Reversible Contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Approach to the adolescent requesting contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Circulating follistatin in the human foetus at term birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Early Origins of polycystic ovary syndrome: hypotheses may change without notice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Insulin as a regulator of androgen biosynthesis by cultured rat ovarian cells: cellular mechanism(s) underlying physiological and pharmacological hormonal actions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Increased prevalence of type 2 diabetes mellitus and impaired glucose tolerance in first-degree relatives of girls with a history of precocious pubarche

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Genetics of polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Incidence of ovulation in the years after the menarche

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Degree of facial and body terminal hair growth in unselected black and white women: toward a populational definition of hirsutism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Defining hirsutism in Chinese women: a cross-sectional study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Longitudinal change of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Lifestyle changes in women with polycystic ovary syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Normative values for intima-media thickness and distensibility of large arteries in healthy adolescents

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol-cyproterone acetate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Divergent effects of ethinylestradiol-drospirenone and flutamide-metformin on follistatin in adolescents and women with hyperinsulinemic androgen excess

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Responsiveness to metformin in girls with androgen excess: collective influence of genetic polymorphisms.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Gestational Diabetes and Type 2 Diabetes in Reproductive-Aged Women With Polycystic Ovary Syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2014.58

Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche

31 March 2020

1 reference

12 December 2020

Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.

1 reference

12 December 2020

Pubertal metformin therapy to reduce total, visceral, and hepatic adiposity

1 reference

12 December 2020

Estrogen receptor-mediated repression of human hepatic lipase gene transcription.

1 reference

12 December 2020

Sexual experience and contraceptive use among female teens - United States, 1995, 2002, and 2006-2010.

1 reference

12 December 2020

Family history as a risk factor for the polycystic ovary syndrome

1 reference

12 December 2020

Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide.

1 reference

12 December 2020

The role of hyperinsulinemia in the pathogenesis of ovarian hyperandrogenism

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2014.58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24776733%20AND%20SRC:MED&resulttype=core&format=json

16 March 2020

1 reference